Clara Rosso-Fernández

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

Manuela Aguilar‐Guisado, Ildefonso Espigado, Almudena Martín‐Peña et al. · The Lancet Haematology · 2017 · 241 citations

Pharmacy, Clinical Sciences, Oncology +15

Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial

José Molina, Enrique Montero-Mateos, Julia Praena‐Segovia et al. · Clinical Microbiology and Infection · 2021 · 136 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros et al. · Journal of Antimicrobial Chemotherapy · 2019 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1–2, a Randomized Controlled Clinical Trial

Elisa Cordero, Cristina Roca-Oporto, Ángel Bulnes‐Ramos et al. · Clinical Infectious Diseases · 2017 · 122 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial

José Miguel Cisneros, Clara Rosso-Fernández, Cristina Roca-Oporto et al. · Critical Care · 2019 · 98 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13